Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Oghenowede Eyawo

Biographic Data

ID5412695
NAMEOghenowede Eyawo
GIVEN NAMESOghenowede
FAMILY NAMEEyawo
SIGNATUREEYAWO O
AFFILIATIONSYork University
ORCID0000-0001-6263-1076
VERIFIEDYes
TOTAL WORKS12
TOTAL CITATIONS1
WORKS AS AUTHOR12
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2011
LATEST PUBLICATION YEAR2024
H-INDEX1
  • Health trends in Canada 1990–2019

    Open Access•Jacek A Kopec, Farshad Pourmalek et al.•ARTICLE•Canadian Journal of Public Health•2024•References: 17

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health

    Open Access•Katherine R Paulson, Katherine Paulson et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Lockdowns and low- and middle-income countries

    Open Access•Oghenowede Eyawo, A M Viens et al.•ARTICLE•Globalization and Health•2021

    Lockdowns can be an effective pandemic response strategy that can buy much needed time to slow disease transmission and adequately scale up preventative, diagnostic, and treatment capacities. However, the broad restrictive measures typically associated with lockdowns, though effective, also comes at a cost – imposing significant social and economic burdens on individuals and societies, especially for those in low- and middle-income countries (LMI…

  • Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV

    Open Access•Kathleen A McGinnis, Janet P Tate et al.•ARTICLE•AIDS and Behavior•2021

  • Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

    Open Access•Gregory A Roth, George A Mensah et al.•ARTICLE•Journal of the American College…•2020

    Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consisten…

  • Covid-19

    Open Access•A M Viens, Oghenowede Eyawo•ARTICLE•BMJ Global Health•2020

    Decades of bad political choices by the elite class has resulted in weakened health systems in many low-and middle-income countries The resulting lack of high-quality care and poor health outcomes are typically only borne by those of lower socio-economic standing -with the elites and their families being able to seek care in high-income countries. COVID-19 may change all that-a highly transmissible virus and restrictive measures that prevent elit…

  • Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories

    Open Access•Tahvi D Frank, Tahvi Frank et al.•ARTICLE•The Lancet HIV•2019

    BACKGROUND: Understanding the patterns of HIV/AIDS epidemics is crucial to tracking and monitoring the progress of prevention and control efforts in countries. We provide a comprehensive assessment of the levels and trends of HIV/AIDS incidence, prevalence, mortality, and coverage of antiretroviral therapy (ART) for 1980-2017 and forecast these estimates to 2030 for 195 countries and territories. METHODS: We determined a modelling strategy for ea…

  • Mortality among people living with HIV/Aids with non-small-cell lung cancer in the modern Haart Era

    Danielle M Smith, Kate Salters et al.•ARTICLE•AIDS Care•2018

    People living with HIV (PLWHA) with adequate access to modern combination antiretroviral therapy (cART) are living longer and experiencing reduced AIDS-related morbidity and mortality. However, increases in non-AIDS related conditions, such as certain cancers, have accompanied these therapeutic advances over time. As such, our study objective was to determine the impact of HIV on all-cause and lung cancer-specific mortality amongst PLWHA with dia…

  • Trends in discharges from the HIV/Aids ward at a tertiary Canadian Hospital from 2005 to 2014

    Denise Jaworsky, Peter W B Phillips et al.•ARTICLE•AIDS Care•2018

    Advances in HIV therapies have transformed HIV infection into a manageable chronic disease. Accordingly, hospital admission trends among people living with HIV may have evolved over time. This study describes discharge diagnoses from the dedicated HIV/AIDS ward at St. Paul's Hospital in Vancouver, Canada. A retrospective database review of admissions to the HIV/AIDS ward between 1 July 2005 and 30 June 2014 was conducted. Primary discharge diagno…

  • Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012

    Open Access•for The Comparative Outcomes and Services utilization Trends study, Kalysha…•ARTICLE•AIDS and Behavior•2017

  • The Holy Grail

    Open Access•Oghenowede Eyawo, Robert S Hogg et al.•ARTICLE•Canadian Journal of Public Health•2013•Cited by: 1•References: 5

  • Suboptimal use of HIV drug resistance testing in a universal health-care setting

    Oghenowede Eyawo, Kimberly A Fernandes et al.•ARTICLE•AIDS Care•2011

    HIV drug resistance testing is recommended as routine part of clinical practice in HIV/AIDS treatment and care. Our objective is to assess the determinants of accessing HIV drug resistance testing and examine the factors associated with resistance testing prior to or after starting highly active antiretroviral therapy (HAART) in a setting where access to HIV care is free and universal. The Longitudinal Investigation into Supportive and Ancillary …

  • The Holy Grail

    Open Access•Oghenowede Eyawo, Robert S Hogg et al.•ARTICLE•Canadian Journal of Public Health•2013•Cited by: 1•References: 5

  • Suboptimal use of HIV drug resistance testing in a universal health-care setting

    Oghenowede Eyawo, Kimberly A Fernandes et al.•ARTICLE•AIDS Care•2011

    HIV drug resistance testing is recommended as routine part of clinical practice in HIV/AIDS treatment and care. Our objective is to assess the determinants of accessing HIV drug resistance testing and examine the factors associated with resistance testing prior to or after starting highly active antiretroviral therapy (HAART) in a setting where access to HIV care is free and universal. The Longitudinal Investigation into Supportive and Ancillary …

  • The Holy Grail

    Open Access•Oghenowede Eyawo, Robert S Hogg et al.•ARTICLE•Canadian Journal of Public Health•2013•Cited by: 1•References: 5

  • Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012

    Open Access•for The Comparative Outcomes and Services utilization Trends study, Kalysha…•ARTICLE•AIDS and Behavior•2017

  • Mortality among people living with HIV/Aids with non-small-cell lung cancer in the modern Haart Era

    Danielle M Smith, Kate Salters et al.•ARTICLE•AIDS Care•2018

    People living with HIV (PLWHA) with adequate access to modern combination antiretroviral therapy (cART) are living longer and experiencing reduced AIDS-related morbidity and mortality. However, increases in non-AIDS related conditions, such as certain cancers, have accompanied these therapeutic advances over time. As such, our study objective was to determine the impact of HIV on all-cause and lung cancer-specific mortality amongst PLWHA with dia…

  • Trends in discharges from the HIV/Aids ward at a tertiary Canadian Hospital from 2005 to 2014

    Denise Jaworsky, Peter W B Phillips et al.•ARTICLE•AIDS Care•2018

    Advances in HIV therapies have transformed HIV infection into a manageable chronic disease. Accordingly, hospital admission trends among people living with HIV may have evolved over time. This study describes discharge diagnoses from the dedicated HIV/AIDS ward at St. Paul's Hospital in Vancouver, Canada. A retrospective database review of admissions to the HIV/AIDS ward between 1 July 2005 and 30 June 2014 was conducted. Primary discharge diagno…

  • Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories

    Open Access•Tahvi D Frank, Tahvi Frank et al.•ARTICLE•The Lancet HIV•2019

    BACKGROUND: Understanding the patterns of HIV/AIDS epidemics is crucial to tracking and monitoring the progress of prevention and control efforts in countries. We provide a comprehensive assessment of the levels and trends of HIV/AIDS incidence, prevalence, mortality, and coverage of antiretroviral therapy (ART) for 1980-2017 and forecast these estimates to 2030 for 195 countries and territories. METHODS: We determined a modelling strategy for ea…

  • Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

    Open Access•Gregory A Roth, George A Mensah et al.•ARTICLE•Journal of the American College…•2020

    Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consisten…

  • Covid-19

    Open Access•A M Viens, Oghenowede Eyawo•ARTICLE•BMJ Global Health•2020

    Decades of bad political choices by the elite class has resulted in weakened health systems in many low-and middle-income countries The resulting lack of high-quality care and poor health outcomes are typically only borne by those of lower socio-economic standing -with the elites and their families being able to seek care in high-income countries. COVID-19 may change all that-a highly transmissible virus and restrictive measures that prevent elit…

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health

    Open Access•Katherine R Paulson, Katherine Paulson et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Lockdowns and low- and middle-income countries

    Open Access•Oghenowede Eyawo, A M Viens et al.•ARTICLE•Globalization and Health•2021

    Lockdowns can be an effective pandemic response strategy that can buy much needed time to slow disease transmission and adequately scale up preventative, diagnostic, and treatment capacities. However, the broad restrictive measures typically associated with lockdowns, though effective, also comes at a cost – imposing significant social and economic burdens on individuals and societies, especially for those in low- and middle-income countries (LMI…

  • Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV

    Open Access•Kathleen A McGinnis, Janet P Tate et al.•ARTICLE•AIDS and Behavior•2021

  • Health trends in Canada 1990–2019

    Open Access•Jacek A Kopec, Farshad Pourmalek et al.•ARTICLE•Canadian Journal of Public Health•2024•References: 17

Medicine (12 works) · Environmental health (9 works) · HIV/AIDS Research and Interventions (6 works) · Disease (5 works) · Population (5 works) · Public health (5 works) · HIV Research and Treatment (4 works) · Internal Medicine (4 works) · Demography (3 works) · Disease burden (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae